financetom
Business
financetom
/
Business
/
Guardant Health, Quest Diagnostics Collaborate on Colorectal Cancer Screening
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Guardant Health, Quest Diagnostics Collaborate on Colorectal Cancer Screening
Sep 24, 2025 5:59 AM

08:36 AM EDT, 09/24/2025 (MT Newswires) -- Guardant Health's ( GH ) Shield colorectal cancer screening test will be made available to physicians and patients served by Quest Diagnostics ( DGX ) in the US, the companies said Wednesday.

Under the companies' multiyear collaboration, Quest's physician clients will be able to directly order Shield starting Q1 of 2026, according to a joint statement.

Shares of Guardant and Quest were each up more than 2% in recent premarket activity Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved